Direct-to-consumer advertising: its effects on stakeholders
Isaac D Montoya1, Gwen Lee-Dukes, Dhvani Shah
1Student Health Center, College of Pharmacy, University of Houston Texas Medical Center, 77030, USA. imontoya@uh.edu
Journal of Allied Health
|July 18, 2008
Summary
Direct-to-consumer (DTC) advertising for pharmaceuticals offers benefits like increased patient knowledge but also drawbacks such as reduced physician productivity and higher costs. This controversial issue impacts various stakeholders in healthcare.
Area of Science:
- Pharmaceutical Marketing
- Healthcare Economics
- Consumer Health Behavior
Background:
- Pharmaceutical companies increasingly use direct-to-consumer (DTC) advertising to market drugs.
- DTC advertising has seen significant growth over the past 15 years.
- This marketing strategy presents both advantages and disadvantages.
Purpose of the Study:
- To provide an overview of direct-to-consumer (DTC) pharmaceutical advertising.
- To analyze the multifaceted effects of DTC advertising.
- To examine the impact on physicians, pharmacists, consumers, insurers, government, and manufacturers.
Main Methods:
- Review of existing literature on DTC pharmaceutical advertising.
- Analysis of reported advantages and disadvantages.
- Examination of stakeholder perspectives.
Main Results:
- Advantages include enhanced consumer knowledge and patient autonomy.
- Disadvantages involve concerns about information quality and physician productivity.
- Increased reimbursement expenditures for insurers are also noted.
Conclusions:
- Direct-to-consumer (DTC) pharmaceutical advertising is a controversial topic with significant implications.
- The effects of DTC advertising create a complex landscape for healthcare stakeholders.
- Further examination is needed to balance benefits against drawbacks.
More Related Videos
07:35How Virtual Celebrity Characteristics Drive Purchase Intention: Testing the Stimulus-Organism-Response Framework with Structural Equation Modeling
Published on: March 3, 2026
06:46Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production
Published on: June 2, 2023
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:27Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
03:26Framing Effects
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in different ways based on the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.